Skip to main content
Top
Published in: Clinical Rheumatology 12/2007

01-12-2007 | Review Article

Capillaroscopy: questions and answers

Authors: Walter Grassi, Rossella De Angelis

Published in: Clinical Rheumatology | Issue 12/2007

Login to get access

Abstract

Capillaroscopy is an essential imaging technique used in the study of microcirculation and one of the best diagnostic tools for the early detection of systemic sclerosis and related conditions. However, despite the increasing interest in capillary microscopy, there is still a surprising discrepancy between its potential application and its still limited use in rheumatological practice. This contrast is really surprising because few diagnostic techniques can combine all the positive features typical of capillaroscopy (low cost, uninvasiveness, repeatability, high sensitivity, good specificity, easy interpretation of results). The lack of guidelines and recommendations concerning the right way to carry out a correct capillaroscopic examination and the interpretation of the most relevant capillaroscopic abnormalities may represent one of the major drawbacks for its widespread use. Discussion about controversies on this topic should be encouraged, leading to a progressive development of capillaroscopy as a routine investigation in rheumatology.
Literature
2.
go back to reference Houtman PM, Kallenberg CGM, Fidler V et al (1986) Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon. J Rheumatol 13:556–563PubMed Houtman PM, Kallenberg CGM, Fidler V et al (1986) Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon. J Rheumatol 13:556–563PubMed
3.
go back to reference Statham BN, Rowell NR (1986) Quantification of the nailfold capillary abnormalities in systemic sclerosis and Raynaud’s phenomenon. Acta Derm Venereol 66:139–143PubMed Statham BN, Rowell NR (1986) Quantification of the nailfold capillary abnormalities in systemic sclerosis and Raynaud’s phenomenon. Acta Derm Venereol 66:139–143PubMed
4.
go back to reference Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16:75–91PubMed Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16:75–91PubMed
6.
go back to reference Lefford F, Edwards JCW (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749CrossRefPubMedPubMedCentral Lefford F, Edwards JCW (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749CrossRefPubMedPubMedCentral
7.
go back to reference Scheja A, Akesson A, Niewierowicz I et al (1996) Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 55:52–56CrossRefPubMedPubMedCentral Scheja A, Akesson A, Niewierowicz I et al (1996) Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 55:52–56CrossRefPubMedPubMedCentral
8.
go back to reference Chen ZY, Silver RM, Ainsworth SK et al (1984) Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 77:812–822CrossRefPubMed Chen ZY, Silver RM, Ainsworth SK et al (1984) Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 77:812–822CrossRefPubMed
9.
go back to reference Lovy M, MacCarter D, Steigerwald JC (1985) Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 28:496–501CrossRefPubMed Lovy M, MacCarter D, Steigerwald JC (1985) Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 28:496–501CrossRefPubMed
10.
go back to reference Schmidt KU, Mensing H (1988) Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 176:18–21CrossRefPubMed Schmidt KU, Mensing H (1988) Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 176:18–21CrossRefPubMed
11.
go back to reference Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
13.
go back to reference LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed
14.
go back to reference Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030CrossRefPubMed Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030CrossRefPubMed
15.
go back to reference Grassi W, Del Medico P, Izzo F et al (2001) Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 30:397–402CrossRefPubMed Grassi W, Del Medico P, Izzo F et al (2001) Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 30:397–402CrossRefPubMed
16.
go back to reference Anders HJ, Sigl T, Schattenkirchner N (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophtalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409CrossRefPubMedPubMedCentral Anders HJ, Sigl T, Schattenkirchner N (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophtalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409CrossRefPubMedPubMedCentral
17.
go back to reference Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nailfold capillaroscopic instrument. Arch Dermatol 139:1027–1030CrossRefPubMed Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nailfold capillaroscopic instrument. Arch Dermatol 139:1027–1030CrossRefPubMed
18.
go back to reference Tektonidou M, Kaskani E, Skopouli FN et al (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830CrossRefPubMed Tektonidou M, Kaskani E, Skopouli FN et al (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830CrossRefPubMed
19.
go back to reference Rozboril MB, Maricq HR, Rodnan GP et al (1983) Capillary microscopy in eosinophilic fasciitis. A comparison with systemic sclerosis. Arthritis Rheum 26:617–622CrossRefPubMed Rozboril MB, Maricq HR, Rodnan GP et al (1983) Capillary microscopy in eosinophilic fasciitis. A comparison with systemic sclerosis. Arthritis Rheum 26:617–622CrossRefPubMed
20.
go back to reference Zaric D, Worm AM, Stahl D et al (1981) Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol 10:249–252CrossRefPubMed Zaric D, Worm AM, Stahl D et al (1981) Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol 10:249–252CrossRefPubMed
21.
go back to reference Grassi W, Core P, Carlino G et al (1992) Nailfold capillary permeability in psoriatic arthritis. Scand J Rheumatol 21:226–230CrossRefPubMed Grassi W, Core P, Carlino G et al (1992) Nailfold capillary permeability in psoriatic arthritis. Scand J Rheumatol 21:226–230CrossRefPubMed
22.
go back to reference Dinc A, Melikoglu M, Korkmaz C et al (2001) Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol 19(Suppl 24):S42–S44PubMed Dinc A, Melikoglu M, Korkmaz C et al (2001) Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol 19(Suppl 24):S42–S44PubMed
23.
go back to reference Vaiopoulos G, Pangratis N, Samarkos M et al (1995) Nailfold capillary abnormalities in Behçet’s disease. J Rheumatol 22:1108–1111PubMed Vaiopoulos G, Pangratis N, Samarkos M et al (1995) Nailfold capillary abnormalities in Behçet’s disease. J Rheumatol 22:1108–1111PubMed
24.
go back to reference Sulli A, Pizzorni C, Cutolo M (2000) Nailfold videocapillaroscopy in patients with antiphospholipid antibodies. J Rheumatol 27:1574–1576PubMed Sulli A, Pizzorni C, Cutolo M (2000) Nailfold videocapillaroscopy in patients with antiphospholipid antibodies. J Rheumatol 27:1574–1576PubMed
25.
go back to reference Grassi W, Core P, Carlino G et al (1994) Capillary permeability in fibromyalgia. J Rheumatol 21:1328–1331PubMed Grassi W, Core P, Carlino G et al (1994) Capillary permeability in fibromyalgia. J Rheumatol 21:1328–1331PubMed
26.
go back to reference Fahrig C, Heidrich H, Voigt B et al (1995) Capillary microscopy of the nailfold in healthy subjects. Int J Microcirc Clin Exp 15:287–292CrossRefPubMed Fahrig C, Heidrich H, Voigt B et al (1995) Capillary microscopy of the nailfold in healthy subjects. Int J Microcirc Clin Exp 15:287–292CrossRefPubMed
27.
go back to reference Herrick AL, Moore T, Hollis S et al (2000) The influence of age on nailfold capillary dimensions in childhood. J Rheumatol 27:797–800PubMed Herrick AL, Moore T, Hollis S et al (2000) The influence of age on nailfold capillary dimensions in childhood. J Rheumatol 27:797–800PubMed
28.
go back to reference Merlen JF (1985) Capillaroscopy at the nailbed in functioning people aged 70 and over. Int Angiol 4:285–288PubMed Merlen JF (1985) Capillaroscopy at the nailbed in functioning people aged 70 and over. Int Angiol 4:285–288PubMed
29.
go back to reference Michoud E, Poensin D, Carpentier PH (1994) Digitized nailfold capillaroscopy. Vasa 23:35–42PubMed Michoud E, Poensin D, Carpentier PH (1994) Digitized nailfold capillaroscopy. Vasa 23:35–42PubMed
30.
go back to reference Bukhari M, Hollis S, Moore T et al (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video-capillaroscopy. Rheumatology 39:506–512CrossRefPubMed Bukhari M, Hollis S, Moore T et al (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video-capillaroscopy. Rheumatology 39:506–512CrossRefPubMed
31.
go back to reference Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold videocapillaroscopy. A new tool for assessment of Raynaud’s phenomenon. J Rheumatol 32:841–848PubMed Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold videocapillaroscopy. A new tool for assessment of Raynaud’s phenomenon. J Rheumatol 32:841–848PubMed
32.
go back to reference Leteurtre E, Hachulla E, Janin A et al (1994) Vascular manifestations of dermatomyositis and polymyositis: clinical, capillaroscopic and histological aspects. Rev Med Interne 15:800–807CrossRefPubMed Leteurtre E, Hachulla E, Janin A et al (1994) Vascular manifestations of dermatomyositis and polymyositis: clinical, capillaroscopic and histological aspects. Rev Med Interne 15:800–807CrossRefPubMed
33.
go back to reference De Angelis R, Bugatti L, Del Medico P et al (2002) Videocapillaroscopic findings in the microcirculation of the psoriatic plaque. Dermatology 204:236–239CrossRefPubMed De Angelis R, Bugatti L, Del Medico P et al (2002) Videocapillaroscopic findings in the microcirculation of the psoriatic plaque. Dermatology 204:236–239CrossRefPubMed
34.
go back to reference Chang CH, Tsai RK, Wu WC et al (1997) Use of dynamic capillaroscopy for studying cutaneous microcirculation in patients with diabetes mellitus. Microvasc Res 53:121–127CrossRefPubMed Chang CH, Tsai RK, Wu WC et al (1997) Use of dynamic capillaroscopy for studying cutaneous microcirculation in patients with diabetes mellitus. Microvasc Res 53:121–127CrossRefPubMed
35.
go back to reference Monticone G, Colonna L, Palermi G et al (2000) Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis. J Am Acad Dermatol 42:787–790CrossRefPubMed Monticone G, Colonna L, Palermi G et al (2000) Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis. J Am Acad Dermatol 42:787–790CrossRefPubMed
36.
go back to reference Fitzgerald O, C’Connor GT, Spencer-Green G (1988) Prospective study on the evolution of Raynaud’s phenomenon. Am J Med 84:718–726CrossRefPubMed Fitzgerald O, C’Connor GT, Spencer-Green G (1988) Prospective study on the evolution of Raynaud’s phenomenon. Am J Med 84:718–726CrossRefPubMed
37.
go back to reference Spencer-Green G (1998) Outcomes in primary Raynaud’s phenomenon. A meta-analysis of frequency, rates and predictors of transition to secondary disease. Arch Intern Med 158:595–600CrossRefPubMed Spencer-Green G (1998) Outcomes in primary Raynaud’s phenomenon. A meta-analysis of frequency, rates and predictors of transition to secondary disease. Arch Intern Med 158:595–600CrossRefPubMed
38.
go back to reference Luggen M, Belhorn L, Evans T et al (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232PubMed Luggen M, Belhorn L, Evans T et al (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232PubMed
39.
go back to reference Maricq HR, Harper FE, Khan MM et al (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud’s phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205PubMed Maricq HR, Harper FE, Khan MM et al (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud’s phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205PubMed
40.
go back to reference ter Borg EJ, Piersma-Wichers G, Smit AJ et al (1994) Serial nailfold capillary microscopy in primary Raynaud’s phenomenon and scleroderma. Semin Arthritis Rheum 24:40–47CrossRefPubMed ter Borg EJ, Piersma-Wichers G, Smit AJ et al (1994) Serial nailfold capillary microscopy in primary Raynaud’s phenomenon and scleroderma. Semin Arthritis Rheum 24:40–47CrossRefPubMed
41.
go back to reference Bredemeier M, Xavier RM, Capobianco KG et al (2004) Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 31:286–294PubMed Bredemeier M, Xavier RM, Capobianco KG et al (2004) Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 31:286–294PubMed
42.
go back to reference Kabasakal Y, Elvins DM, Ring EFJ et al (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512CrossRefPubMedPubMedCentral Kabasakal Y, Elvins DM, Ring EFJ et al (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512CrossRefPubMedPubMedCentral
43.
go back to reference Cutolo M, Pizzorni C, Tuccio M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726CrossRefPubMed Cutolo M, Pizzorni C, Tuccio M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726CrossRefPubMed
44.
go back to reference Jayson MIV (1984) The microcirculation in systemic sclerosis. Clin Exp Rheumatol 2:85–91PubMed Jayson MIV (1984) The microcirculation in systemic sclerosis. Clin Exp Rheumatol 2:85–91PubMed
45.
go back to reference Wigley FM, Wise RA, Miller R et al (1992) Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 35:688–693CrossRefPubMed Wigley FM, Wise RA, Miller R et al (1992) Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 35:688–693CrossRefPubMed
46.
go back to reference Grassi W, Core P, Carlino G et al (1994) Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum 37:384–390CrossRefPubMed Grassi W, Core P, Carlino G et al (1994) Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum 37:384–390CrossRefPubMed
47.
go back to reference Filaci G, Cutolo M, Scudeletti M et al (1999) Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 38:992–996CrossRefPubMed Filaci G, Cutolo M, Scudeletti M et al (1999) Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 38:992–996CrossRefPubMed
48.
go back to reference Faggioli P, Giani L, Mazzone A (2006) Possibile role of iloprost (stable analogue of PGI2) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 24:220PubMed Faggioli P, Giani L, Mazzone A (2006) Possibile role of iloprost (stable analogue of PGI2) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 24:220PubMed
Metadata
Title
Capillaroscopy: questions and answers
Authors
Walter Grassi
Rossella De Angelis
Publication date
01-12-2007
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0681-3

Other articles of this Issue 12/2007

Clinical Rheumatology 12/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.